SOLENO THERAPEUTICS INC's ticker is and the CUSIP is 834203309. A total of 21 filers reported holding SOLENO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,579,842 | +315.4% | 392,404 | -39.6% | 0.99% | +266.3% |
| Q2 2023 | $2,787,818 | +86.3% | 649,841 | -7.1% | 0.27% | +134.8% |
| Q1 2023 | $1,496,639 | +25.1% | 699,364 | +15.8% | 0.12% | +47.4% |
| Q4 2022 | $1,196,274 | +18.6% | 604,179 | 0.0% | 0.08% | +20.0% |
| Q3 2022 | $1,009,000 | – | 604,179 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 1,201,506 | $2,007,000 | 0.69% |
| AIGH Capital Management LLC | 424,089 | $708,000 | 0.22% |
| Granite Point Capital Management, L.P. | 176,456 | $295,000 | 0.12% |
| Worth Venture Partners, LLC | 105,513 | $176,000 | 0.11% |
| Nantahala Capital Management | 604,179 | $1,009,000 | 0.06% |
| J. Goldman & Co LP | 44,999 | $75,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 37 | $0 | 0.00% |
| VANGUARD GROUP INC | 121,086 | $202,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 358 | $1,000 | 0.00% |